MedTrace Logo

Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries

NCT06590675 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2025-07-03

No results posted yet for this study

Summary

The overall goal of the ChlorHexidine gluconate (CHG) bAthing pRotocol for healthcare settings in low- and Middle-income countries (CHARM) study is to explore the safety, efficacy and feasibility of utilizing a locally prepared CHG solution and bathing protocol among hospitalized neonates to reduce bacterial colonization and healthcare-associated infection (HAI) burden in hospitalized patients.

Conditions

  • Multidrug Resistant Bacterial Infection

Interventions

DRUG

Chlorhexidine Gluconate (CHG)

A locally-prepared CHG formulation as a 1% or 2% solution

Sponsors & Collaborators

Principal Investigators

  • Ebbing Lautenbach, MD,MPH,MSCE · University of Pennsylvania

  • Susan Coffin, MD,MPH · Children's Hospital of Philadelphia

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
1 Day
Max Age
6 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-19
Primary Completion
2025-03-19
Completion
2025-03-19

Countries

  • Botswana

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06590675 on ClinicalTrials.gov